Aaron Steiner, who knew of the Haiti Program when he was earning a bachelor of management degree at Notre Dame in 2010, decided to volunteer for three weeks this summer between his consulting job at Deloitte and the start of his MBA program at the University of Michigan. The experience left the Haiti Program with a strategic business plan for increasing fortified-salt market share in three communities. It also left Steiner with a deepened appreciation for the social benefits of business.
We are fighting to eliminate lymphatic filariasis, a mosquito-borne disease endemic in Haiti, by 2020
See how the program is expanding our work in Haiti.
Learn more about the life and passion of Fr. Thomas Streit, C.S.C., the founder and director of the Haiti Program.
Donate online today
Online giving for the Notre Dame Haiti Program is now available. Learn more.
A note from the managing director regarding the 2015 MDA in Haiti
The initial response to our program need to fund DEC (diethylcarbamize citrate) pills in support of the Spring 2015 MDA cycle in Haiti has been substantial and most heartening. The cost of the drug is a little less than three cents per person treated. The following table illustrates the impact you can have as we seek to treat over five million people:
|$100||Will purchase DEC pills for about 4,000 Haitians|
|$500||Will purchase DEC pills for about 20,000 Haitians|
|$1000||Will purchase DEC pills for about 40,000 Haitians|
|$5000||Will purchase DEC pills for about 200,000 Haitians|
On behalf of Fr. Tom and all of the team, thanks so much for your partnership and generosity!
Yours in Notre Dame...and for Haiti,
Almost half of the population in endemic areas of Haiti suffer from Lymphatic Filariasis.
Founded in 1993, the University of Notre Dame Haiti Program seeks to achieve the historic goal of eliminating Lymphatic Filariasis (LF) in Haiti by 2020. LF, a mosquito-borne disease that affects over 2 million Haitians, is the second leading cause of long-term disfigurement and disability worldwide. It can be eliminated in Haiti through mass drug administration and the distribution of co-fortified salt. The Haiti Program is partnering with the Haitian Ministry of Health, corporations, and non-governmental organizations to forever eliminate the disease in Haiti and alleviate the suffering of Haitians infected with LF. Our innovative work also provides an exportable model for LF elimination in other developing nations.
Annie Sescleifer, a 2105 Biological Sciences graduate with a minor in International Development Studies, is volunteering with the Haiti Program for a year before she goes on to medical school and a career in medicine and global health. Sescleifer met program founder Rev. Thomas Streit when she was a freshman, and he advised her capstone project that studied the effectiveness of fortified salt to fight lymphatic filariasis (LF) in a region of the Dominican Republic with a high population of Haitian immigrants.